期刊文献+

超抗原SEA与抗黑色素瘤ScFv融合基因的构建及表达

The Construction and Expression of Superantigen SEA and Antimelanoma ScFv Fusion Gene
在线阅读 下载PDF
导出
摘要 采用酶切连接和重叠PCR连接两种方法将抗黑色素瘤单链抗体基因和去除N端信号肽的金黄色葡萄球菌肠毒素A基因进行融合 ,并将融合基因克隆于pET2 8 a表达载体上 ,转化大肠杆菌BL2 1(DE3)。用Ni NTA系统对表达产物进行分离、纯化。MTT法检测融合蛋白对黑色素瘤细胞的体外抑制率。结果表明 6His ScFv SEA融合蛋白可在E .coliBL2 1(DE3)中稳定表达 ,表达量占菌体蛋白的 30 % ,主要以包涵体的形式存在。融合蛋白可通过激活效应细胞对表达相关抗原的黑色素瘤细胞发挥抑制作用。 Two strategies, direct ligation after enzyme digestion and over-lap PCR technology, were adopted to construct a fusion gene which was composed of the antimelanoma single chain antibody gene and the staphylococcal enterotoxin A gene without N-terminal signal sequence. The fusion gene was subcloned into pET28-a vector and transformed into E. coli BL21(DE3). Ni-NTA system was selected to separate and purify the expresstd products. The inhibition ratio of the fusion protein was tested by MTT method. It is shown that the 6His-ScFv-SEA fusion protein can be expressed stably in E. coli BL21 (DE3). The quantity of the fusion protein was shown up to 30% of the total protein of the bacteria and mainly in inclusion body. By activation the effective cells,the fution protein can inhibit the melanoma cell whith expressed corresponding antigen.
出处 《生物工程学报》 CAS CSCD 北大核心 2003年第6期750-753,共4页 Chinese Journal of Biotechnology
基金 沈阳应用生态研究所与屹昌科技集团股份有限公司合作项目~~
关键词 抗黑色素瘤单链抗体 金黄色葡萄球菌肠毒素A 融合蛋白 靶向治疗 基因表达 antimelanoma single chain antibody, staphylococcal enterotoxin A, fusion protein, target therapy
  • 相关文献

参考文献2

二级参考文献14

  • 1Bergdoll M S,Staphylococcal intoxications.In Riemann H and Bryan F L(ed),Foodborn infections and intoxications.Academic Press.Inc NewYork,1979,pp.443~493
  • 2Fleischer B,Schrezenmeier H.T lymphocyte activation by staphylococcal enterotoxins: role of class Ⅱ molecules and T cell surface structure.Cell Immunol,1989,120(1): 92~101
  • 3Philippa Marrack,John Kappler.The staphylococcal enterotoxins and their relatives.Science,1990,148:705~711
  • 4Shcheglovitova ON.Non-specific antitumoral activity of staphylococcal enterotoxins.Eksp Onkol,1987,9 ( 1 ): 28~30
  • 5Kalland T,Dohlsten M,Lind P.Monoclonal antibodies and superantigens:a novel therapeutic approach.Med Oncol Tumor Pharmacother,1993:10(1~2) :37~47
  • 6Mikael.Dohlsten,Lars.Abrahmsen,PerBjork,Monoclonal antibody-superantigen fusion proteins: Tumor specific agents for T-cellbased tumor therapy.Proc Natl Acad Sci USA,1994,191:8945~8949
  • 7Kalland T,Dohlsten M,Lind P.Monoclonal antibodies and superantigens: a novel therapeutic approach.Oncol Tumor Pharmacother,1993,10(1~2) :37~47
  • 8Alpaugh R K,Schultz J,McAleer C.Superantigen-targeted therapy:phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.Clin Cancer Res,1998,4(8): 1903~1914
  • 9Marsha J,Betley,John J Mekalanos.Nucleotide Sequence of the Type A staphylococcal enterotoxin.Gene J Bacteriol,1988,170:34~43
  • 10Sharp P M,Devine K M.Codon usage and gene expression level in Dictyostelium discoideum: highly expressed genes do ‘prefer' optimal codons.Nucleic Acids Res,1989,11; 17(13) :5029~5039

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部